Physician profile
David Bolon
NPI 1033184205
$1,948.26
in general payments reported to CMS, 2019-2025
20 companies · $191 in 2025
The $191 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $536 · 2022: $92.56 · 2023: $512 · 2024: $616 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,320.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $535.67 | 2021 | |
| Medicomp INC | $307.07 | 2023-2025 | Telepatch Cardiac Monitor |
| Pfizer INC. | $249.02 | 2022-2025 | |
| Lilly USA, LLC | $134.02 | 2022-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $101.16 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $98.95 | 2024-2025 | |
| Amgen INC. | $67.97 | 2024-2025 | Repatha, Repatha |
| Esperion Therapeutics, INC. | $67.66 | 2023-2024 | Nexletol |
| Idorsia Pharmaceuticals US INC | $65.14 | 2022-2023 | Quviviq |
| Astrazeneca Pharmaceuticals LP | $63.01 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.66 | 2023-2025 | Jardiance |
| Boston Scientific Corporation | $31.50 | 2024 | Watchman Flx |
| Irhythm Technologies, INC. | $28.91 | 2024 | Zio Monitor, Zio Xt Patch |
| Inspire Medical Systems, INC. | $23.05 | 2024 | Inspire |
| Bardy Diagnostics, INC. | $22.00 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $20.64 | 2023 | Ffrct |
| Actelion Pharmaceuticals US, INC. | $20.50 | 2025 | Opsumit, Uptravi |
| Medtronic, INC. | $19.18 | 2023 | Cg Future |
| Bayer Healthcare Pharmaceuticals INC. | $18.94 | 2023 | |
| Merck Sharp & Dohme LLC | $17.21 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bolon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.